Anaphylatoxin Receptor C3aR Contributes to Platelet Function, Thrombus Formation and In Vivo Haemostasis

Reinhard J. Sauter; Manuela Sauter; Marcus Obrich; Frederic N. Emschermann; Henry Nording; Johannes Patzelt; Hans Peter Wendel; Jan-Christian Reil; Frank Edlich; Harald F. Langer

doi:10.1055/s-0038-1676349

Thrombosis and Haemostasis, Inhaltsverzeichnis

Thromb Haemost 2019; 119(01): 179-182
DOI: 10.1055/s-0038-1676349

Letter to the Editor

Georg Thieme Verlag KG Stuttgart · New York

Anaphylatoxin Receptor C3aR Contributes to Platelet Function, Thrombus Formation and In Vivo Haemostasis

Reinhard J. Sauter^*

¹Department of Cardiology and Cardiovascular Medicine, University Clinic, Eberhard Karls University of Tübingen, Tübingen, Germany

²Section for Cardioimmunology, Eberhard Karls University of Tübingen, Tübingen, Germany

,

Manuela Sauter^*

²Section for Cardioimmunology, Eberhard Karls University of Tübingen, Tübingen, Germany

,

Marcus Obrich

²Section for Cardioimmunology, Eberhard Karls University of Tübingen, Tübingen, Germany

,

Frederic N. Emschermann

²Section for Cardioimmunology, Eberhard Karls University of Tübingen, Tübingen, Germany

,

Henry Nording

¹Department of Cardiology and Cardiovascular Medicine, University Clinic, Eberhard Karls University of Tübingen, Tübingen, Germany

²Section for Cardioimmunology, Eberhard Karls University of Tübingen, Tübingen, Germany

,

Johannes Patzelt

¹Department of Cardiology and Cardiovascular Medicine, University Clinic, Eberhard Karls University of Tübingen, Tübingen, Germany

²Section for Cardioimmunology, Eberhard Karls University of Tübingen, Tübingen, Germany

,

Hans Peter Wendel

³Department of Thoracic and Cardiovascular Surgery, University Clinic, Eberhard Karls University of Tübingen, Tübingen, Germany

,

Jan-Christian Reil

⁴Klinik für Innere Medizin II, Kardiologie, Angiologie und Internistische Intensivmedizin, Universitätsklinikum Schleswig-Holstein, Campus Lübeck, Lübeck, Germany

,

Frank Edlich

⁵Institute for Biochemistry and Molecular Biology, University of Freiburg, Freiburg, Germany

⁶BIOSS, Centre for Biological Signaling Studies, University of Freiburg, Freiburg, Germany

,

Harald F. Langer

¹Department of Cardiology and Cardiovascular Medicine, University Clinic, Eberhard Karls University of Tübingen, Tübingen, Germany

²Section for Cardioimmunology, Eberhard Karls University of Tübingen, Tübingen, Germany

References
1 Ricklin D, Hajishengallis G, Yang K, Lambris JD. Complement: a key system for immune surveillance and homeostasis. Nat Immunol 2010; 11 (09) 785-797
2 Langer HF, Chung KJ, Orlova VV. , et al. Complement-mediated inhibition of neovascularization reveals a point of convergence between innate immunity and angiogenesis. Blood 2010; 116 (22) 4395-4403
3 Hertle E, van Greevenbroek MM, Arts IC. , et al. Distinct associations of complement C3a and its precursor C3 with atherosclerosis and cardiovascular disease. The CODAM study. Thromb Haemost 2014; 111 (06) 1102-1111
4 Amara U, Rittirsch D, Flierl M. , et al. Interaction between the coagulation and complement system. Adv Exp Med Biol 2008; 632: 71-79
5 Del Conde I, Crúz MA, Zhang H, López JA, Afshar-Kharghan V. Platelet activation leads to activation and propagation of the complement system. J Exp Med 2005; 201 (06) 871-879
6 Subramaniam S, Jurk K, Hobohm L. , et al. Distinct contributions of complement factors to platelet activation and fibrin formation in venous thrombus development. Blood 2017; 129 (16) 2291-2302
7 Schleicher RI, Reichenbach F, Kraft P. , et al. Platelets induce apoptosis via membrane-bound FasL. Blood 2015; 126 (12) 1483-1493
8 Kraft P, Schleicher R, Olbrich M. , et al. Platelet derived FasL contributes to apoptosis in stroke. Thromb Haemost 2016; 116 (05) 998-1000
9 Langer HF, Gawaz M. Platelet-vessel wall interactions in atherosclerotic disease. Thromb Haemost 2008; 99 (03) 480-486
10 Massberg S, Gawaz M, Grüner S. , et al. A crucial role of glycoprotein VI for platelet recruitment to the injured arterial wall in vivo. J Exp Med 2003; 197 (01) 41-49
11 Distelmaier K, Adlbrecht C, Jakowitsch J. , et al. Local complement activation triggers neutrophil recruitment to the site of thrombus formation in acute myocardial infarction. Thromb Haemost 2009; 102 (03) 564-572
12 Hajishengallis G, Reis ES, Mastellos DC, Ricklin D, Lambris JD. Novel mechanisms and functions of complement. Nat Immunol 2017; 18 (12) 1288-1298
13 Reca R, Mastellos D, Majka M. , et al. Functional receptor for C3a anaphylatoxin is expressed by normal hematopoietic stem/progenitor cells, and C3a enhances their homing-related responses to SDF-1. Blood 2003; 101 (10) 3784-3793
14 Ruggeri ZM. Platelets in atherothrombosis. Nat Med 2002; 8 (11) 1227-1234
15 Strainic MG, Liu J, Huang D. , et al. Locally produced complement fragments C5a and C3a provide both costimulatory and survival signals to naive CD4+ T cells. Immunity 2008; 28 (03) 425-435
16 Borst O, Münzer P, Gatidis S. , et al. The inflammatory chemokine CXC motif ligand 16 triggers platelet activation and adhesion via CXC motif receptor 6-dependent phosphatidylinositide 3-kinase/Akt signaling. Circ Res 2012; 111 (10) 1297-1307
17 Sauter RJ, Sauter M, Reis ES. , et al. A functional relevance of the anaphylatoxin receptor C3aR for platelet function and arterial thrombus formation marks an intersection point between innate immunity and thrombosis. Circulation 2018; 138 (16) 1720-1735
18 Yin H, Stojanovic A, Hay N, Du X. The role of Akt in the signaling pathway of the glycoprotein Ib-IX induced platelet activation. Blood 2008; 111 (02) 658-665
19 Kildsgaard J, Hollmann TJ, Matthews KW, Bian K, Murad F, Wetsel RA. Cutting edge: targeted disruption of the C3a receptor gene demonstrates a novel protective anti-inflammatory role for C3a in endotoxin-shock. J Immunol 2000; 165 (10) 5406-5409
20 Elzey BD, Tian J, Jensen RJ. , et al. Platelet-mediated modulation of adaptive immunity. A communication link between innate and adaptive immune compartments. Immunity 2003; 19 (01) 9-19
21 Gushiken FC, Han H, Li J, Rumbaut RE, Afshar-Kharghan V. Abnormal platelet function in C3-deficient mice. J Thromb Haemost 2009; 7 (05) 865-870
22 Jackson SP, Schoenwaelder SM, Goncalves I. , et al. PI 3-kinase p110beta: a new target for antithrombotic therapy. Nat Med 2005; 11 (05) 507-514
23 Cosemans JM, Munnix IC, Wetzker R, Heller R, Jackson SP, Heemskerk JW. Continuous signaling via PI3K isoforms beta and gamma is required for platelet ADP receptor function in dynamic thrombus stabilization. Blood 2006; 108 (09) 3045-3052
24 Patzelt J, Verschoor A, Langer HF. Platelets and the complement cascade in atherosclerosis. Front Physiol 2015; 6: 49
25 Nording H, Langer HF. Complement links platelets to innate immunity. Semin Immunol 2018; 37: 43-52
26 Verschoor A, Langer HF. Crosstalk between platelets and the complement system in immune protection and disease. Thromb Haemost 2013; 110 (05) 910-919
27 Ricklin D, Mastellos DC, Reis ES, Lambris JD. The renaissance of complement therapeutics. Nat Rev Nephrol 2018; 14 (01) 26-47
28 Ricklin D, Lambris JD. Complement-targeted therapeutics. Nat Biotechnol 2007; 25 (11) 1265-1275
29 Vogel CW, Fritzinger DC, Gorsuch WB, Stahl GL. Complement depletion with humanised cobra venom factor: efficacy in preclinical models of vascular diseases. Thromb Haemost 2015; 113 (03) 548-552

Zusatzmaterial

Supplementary Material